Patent Foramen Ovale in Young Adults with Unexplained Stroke
NEJM 353:2361-2372, Kizer,J.R. &Devereux,R.B., 2005
Dysphagia After Stroke
Stroke 36:2756-2763, Martino,R.,et al, 2005
Mitral Annular Calcification, Aortic Valve Sclerosis, and Incident Stroke in Adults Free of Clinical Cardiovascular Disease
Stroke 36:2533-2537,2523, Kizer,J.R.,et al, 2005
Urinary Retention Caused by a Small Cortical Infarction
JNNP 76:457-458, Funakoshi,K., et al, 2005
Spontaneous Lobar Hemorrhage in CADASIL
JNNP 76:456-457, MacLean,A.V., et al, 2005
Recurrent Stroke Associated With Cannabis Use
JNNP 76:435-437, Mateo,I., et al, 2005
Timing of TIAs Preceding Stroke
Neurol 64:817-820, Rothwell, P.M. & Warlow, C.P., 2005
Severe Sensory Neuropathy Associated With Long-Term Linezolid Use
Neurol 64:926-927, Zivkovic,S.A. & Lacomis, D., 2005
Atypical Antipsychotic Drugs and Risk of Ischaemic Stroke: Population Based Retrospective Cohort Study
BMJ 330:445-448, Gill,S.S., et al, 2005
Visual Field Defect and Intracerebral Hemorrhage Associated with use of Vardenafil (Levitra)
Neurol 64:1095, McGee,H.T., et al, 2005
Sonothrombolysis in Acute Ischemic Stroke for Patients Ineligible for rt-PA
Neurol 64:1052-1054, Eggers,J., et al, 2005
Prospective Reliability of the Stroke Doc Wireless/Site Independent Telemedicine System
Neurol 64:1058-1060, Meyer,B.C., et al, 2005
Acquired Stuttering Secondary to Callosal Infarction
Neurol 64:1092-1093, Hamano,T., et al, 2005
Prognostic Significance of Admission Levels of Troponin I in Patients With Acute Ischaemic Stroke
JNNP 76:76-81, Di Angelantonio,E.,et al, 2005
Update on Susacs Syndrome
Curr Opin Neurol 18:311-314, Gross,M. &Eliashar,R., 2005
Reversible Posterior Leukoencephalopathy Syndrome
Intern Med J 35:83-90, Stott,V.L.,et al, 2005
The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase
Stroke 36:66-73, Hacke,W.,et al, 2005
Posterior Cerebral Artery Stroke
e medicine, Hill,M.D., 2005
Stroke or Encephalitis?
Emerg Med Australas 17:401-404, Townend,B.S.,et al, 2005
Migraine and Cerebral White Matter Lesions
The Neurologist 11:19-29, Gladstone,J.P. &Dodick,D.W., 2005
Expanding Indications for Statins in Cerebral Ischemia
Arch Neurol 62:67-72,23, Ovbiagele,B.,et al, 2005
Risk Factors for Stroke in Subjects With Normal Blood Pressure
Stroke 36:234-238, Li,C., et al, 2005
Outdoor Air Pollution and Stroke in Sheffield, United Kingdom
Stroke 36:239-243, Maheswaran, R., et al, 2005
Chlamydia pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila in Elderly Patients With Stroke (C-PEPS, M-PEPS, L-PEPS)
Stroke 36:259-263, Ngeh, J. & Goodbourn, C., 2005
Telemedicine for Safe and Extended Use of Thrombolysis in Stroke
Stroke 36:287-291, Audebert, H.J., et al, 2005
Aggressive Mechanical Clot Disruption
Stroke 36:292-296, Noser, E.A., et al, 2005
Meningovascular syphilis as a cause of basilar artery stenosis
Neurol 64:391-392, Flint, A.C., et al, 2005
Combined IV and intra-arterial thrombolysis for acute ischemic stroke
Neurol 64:386-388, Flaherty, M.L., et al, 2005
Do the Brain Attack Coalition's Criteria for Stroke Centers Improve Care for Ischemic Stroke?
Neurol 64:422-427, Douglas, V.C., et al, 2005
Ischaemic Stroke in Young Adults: Predictors of Outcome and Recurrence
JNNP 76:191-195, Nedeltchev, K., et al, 2005
Effects of Reviparin, a Low-Molecular-Weight Heparin, on Mortality, Reinfarction, and Strokes in Patients With Acute Myocardial Infarction Presenting With ST-Segment Elevation
JAMA 293:427-436, The CREATE Trial Group Investigators, 2005
The Pathophysiology of Watershed Infarction in Internal Carotid Artery Disease
Stroke 36:567-577, Momjian-Mayor, I. & Baron, J-C., 2005
Effect of Timing and Method of Enteral Tube Feeding For Dysphagic Stroke Patients (FOOD): a Multicentre Randomised Controlled Trial
Lancet 365:764-772, 729, The FOOD Trial Collaboration, 2005
Post-Varicella Arteriopathy of Childhood Natural History of Vascular Stenosis
Neurol 64:660-663, Lanthier,S., et al, 2005
Reasons for Exclusion From Thrombolytic Therapy Following Acute Ischemic Stroke
Neurol 64:719-720, Cocho,D., et al, 2005
Risk of Ischaemic Stroke in People With Migraine: Systemic Review and Meta-analysis of Observational Studies
BMJ 330:63-65, 54, Etminan,M.,et al, 2005
Homocysteine and Stroke: Evidence on a Causal Link From Mendelian Randomisation
Lancet 365:224-232, 194, Casas, J.P., et al, 2005
Association Between Hormone Replacement Therapy and Subsequent Stroke: A Meta-analysis
BMJ 330:342-345, Bath, P.M.W. & Gray, L.J., 2005
Recurrent Stroke Associated with Cannabis Use
JNNP 76:435-437, Mateo,I.,et al, 2005
Urinary Retention Caused by a Small Cortical Infarction
JNNP 76:457-458, Funakashi,K., et al, 2005
Identification of Embolic Stroke Patterns by Diffusion-Weighted MRI in Clinically Defined Lacunar Stroke Syndromes
Stroke 36:757-761, Wessels,T.,et al, 2005
Recovery from Aphasia After Hemicraniectomy for Infarction of the Speech-Dominant Hemisphere
Stroke 36:825-829, Kastrau,F.,et al, 2005
Intravascular Lymphoma: Magnetic Resonance Imaging Correlates of Disease Dynamics Within the Central Nervous System
JNNP 76:540-544, Baehring,J.M.,et al, 2005
Clinical Significance of Detection of Multiple Acute Brain Infarcts on Diffusion Weighted Magnetic Resonance Imaging
JNNP 76:514-518, Caso,V.,et al, 2005
Blood Pressure Control and Risk of Stroke
Stroke 36:725-730, Li,C.,et al, 2005
Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients with Nonrheumatic ATrial Fibrillation and a History of Stroke or Transient Ischemic Attack
Stroke 36:914-915, Saxena,R. &Koudstaal,P.J., 2005
Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 36:916-921, Adams,H.,et al, 2005
Comparison of Warfarin and Aspirin for Symptomatic Intracranial Arterial Stenosis
NEJM 352:1305-1316, 1368, Chimowitz,M.I.,et al, 2005
Ximelagatran vs Warfarin for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation
JAMA 293:690-698,736, SPORTIF Executive Steering Committee for the SPORTIF V Investigators, 2005
Costs and Effectiveness of Ximelagatran for Stroke Prophylaxis in Chronic Atrial Fibrillation
JAMA 293:699-706, OBrien,C.L. &Gage,B.F., 2005